CYCLERION THERAPEUTICS INC CYCN 深 滬
已收盤 09-20 16:00:00 美东时间
2.93
+0.100
+3.53%
華盛通- 最 高2.95
- 今 開2.905
- 成交量 3409股
- 最 低 2.81
- 昨 收 2.83
- 總市值 794.06万
- 52周最高 5.25
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.7501
- 委 比 37.66%
- 總股本 271.01万
- 歷史最高 296.60
- 量 比 1.41
- 振 幅 4.95%
- 歷史最低 1.90
- 每 手 1
- 風險率 0.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cyclerion Therapeutics Q2 EPS $(0.53) Up From $(1.83) YoY
Cyclerion Therapeutics (NASDAQ:CYCN) reported quarterly losses of $(0.53) per share. This is a 71.04 percent increase over losses of $(1.83) per share from the same period last year.
08-27 21:58
Cyclerion Therapeutics names Regina Graul as CEO
Cyclerion Therapeutics (NASDAQ:CYCN) said it has appointed Regina Graul as CEO and president. Graul had joined the company as president in early December last year. More on Cyclerion Therapeutics Fina...
08-07 20:16
快讯 | Cyclerion Therapeutics：Regina Graul晋升为CEO，总裁。
Cyclerion Therapeutics: Regina Graul Promoted to CEO, President
08-07 19:17
Alector Inc盘中异动 早盘大幅拉升5.44%
北京时间2024年01月26日22时39分，Alector Inc（ALEC.us）股票出现异动，股价快速拉升5.44%。截至发稿，该股报6.40美元/股，成交...
01-26 22:39
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares moved upwards by 33.2% to $...
2023-10-11 01:31
Stocks That Hit 52-Week Lows On Wednesday
Wednesday saw 59 companies set new 52-week lows.
2023-07-27 00:18
Cyclerion Regains Compliance With Nasdaq Minimum Bid Price Requirement
Cyclerion's stock will continue to be listed and traded on the Nasdaq Capital Market.
2023-06-02 04:01
Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New Investors
Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (formerly CY6463) and CY3018, to a new private company ("NewCo") formed by certain current Cyclerion shareholders and new investors who have agreed to
2023-05-13 00:59
Cyclerion Therapeutics Reports Q1 Net Loss Of $(7.0)M Vs $(13.0)M Last Year
Net loss was approximately $(7.0) million for Q1 2023, as compared to approximately $(13.0) million for Q1 2022.
2023-05-12 06:07
Cyclerion Inks Definitive Agreement For Zagociguat And CY3018
Certain Cyclerion shareholders and new investors have agreed to invest $81M to launch a new company targeting diseases of mitochondrial dysfunction. Cyclerion will receive $8 million in cash
2023-05-12 06:03
